We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.88%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.86B
AUM Growth
-$168M
(-1.7%)
Cap. Flow
-$326M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J&J Snack Foods
JJSF
|
+$29.7M |
| 2 |
WD-40
WDFC
|
+$28.7M |
| 3 |
CBIZ
CBZ
|
+$27.6M |
| 4 |
Exponent
EXPO
|
+$19.4M |
| 5 |
ANDG
Andersen Group
ANDG
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haemonetics
HAE
|
+$42.3M |
| 2 |
Coherent
COHR
|
+$31.6M |
| 3 |
MKS Inc
MKSI
|
+$31.2M |
| 4 |
Sterling Infrastructure
STRL
|
+$30M |
| 5 |
Installed Building Products
IBP
|
+$28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.96% |
| 2 | Technology | 18.79% |
| 3 | Financials | 16.43% |
| 4 | Consumer Discretionary | 12.93% |
| 5 | Healthcare | 9.22% |
Similar funds
GI
IIM
ACA
VPIM
RI
OIA
LWCFA
HRCM
Royce & Associates's Q4 2025 Portfolio in Review
As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.
- Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
- Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
- Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
- Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
- Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
- Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
- Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.
Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.